These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Structure of cyclin G-associated kinase (GAK) trapped in different conformations using nanobodies. Chaikuad A; Keates T; Vincke C; Kaufholz M; Zenn M; Zimmermann B; Gutiérrez C; Zhang RG; Hatzos-Skintges C; Joachimiak A; Muyldermans S; Herberg FW; Knapp S; Müller S Biochem J; 2014 Apr; 459(1):59-69. PubMed ID: 24438162 [TBL] [Abstract][Full Text] [Related]
27. Identification of the universal cofactor (auxilin 2) in clathrin coat dissociation. Umeda A; Meyerholz A; Ungewickell E Eur J Cell Biol; 2000 May; 79(5):336-42. PubMed ID: 10887964 [TBL] [Abstract][Full Text] [Related]
28. miR-206 inhibits renal cell cancer growth by targeting GAK. Wei C; Wang S; Ye ZQ; Chen ZQ J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):852-858. PubMed ID: 27924503 [TBL] [Abstract][Full Text] [Related]
29. Cyclin G-associated kinase regulates protein phosphatase 2A by phosphorylation of its B'γ subunit. Naito Y; Shimizu H; Kasama T; Sato J; Tabara H; Okamoto A; Yabuta N; Nojima H Cell Cycle; 2012 Feb; 11(3):604-16. PubMed ID: 22262175 [TBL] [Abstract][Full Text] [Related]
30. Depletion of GAK/auxilin 2 inhibits receptor-mediated endocytosis and recruitment of both clathrin and clathrin adaptors. Lee DW; Zhao X; Zhang F; Eisenberg E; Greene LE J Cell Sci; 2005 Sep; 118(Pt 18):4311-21. PubMed ID: 16155256 [TBL] [Abstract][Full Text] [Related]
31. Quantitative assessment of the association between GAK rs1564282 C/T polymorphism and the risk of Parkinson's disease. Ma ZG; He F; Xu J J Clin Neurosci; 2015 Jul; 22(7):1077-80. PubMed ID: 25975492 [TBL] [Abstract][Full Text] [Related]
32. Pyridinyl imidazole compounds interfere with melanosomes sorting through the inhibition of cyclin G-associated Kinase, a regulator of cathepsins maturation. Bellei B; Pitisci A; Migliano E; Cardinali G; Picardo M Cell Signal; 2014 Apr; 26(4):716-23. PubMed ID: 24412755 [TBL] [Abstract][Full Text] [Related]
33. Clathrin heavy chain phosphorylated at T606 plays a role in proper cell division. Yabuno Y; Uchihashi T; Sasakura T; Shimizu H; Naito Y; Fukushima K; Ota K; Kogo M; Nojima H; Yabuta N Cell Cycle; 2019 Aug; 18(16):1976-1994. PubMed ID: 31272276 [TBL] [Abstract][Full Text] [Related]
34. LncRNA OIP5-AS1/cyrano suppresses GAK expression to control mitosis. Kim J; Noh JH; Lee SK; Munk R; Sharov A; Lehrmann E; Zhang Y; Wang W; Abdelmohsen K; Gorospe M Oncotarget; 2017 Jul; 8(30):49409-49420. PubMed ID: 28472763 [TBL] [Abstract][Full Text] [Related]
35. Cyclin G-associated kinase: a novel androgen receptor-interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancer. Ray MR; Wafa LA; Cheng H; Snoek R; Fazli L; Gleave M; Rennie PS Int J Cancer; 2006 Mar; 118(5):1108-19. PubMed ID: 16161052 [TBL] [Abstract][Full Text] [Related]
37. SNCA but not DNM3 and GAK modifies age at onset of LRRK2-related Parkinson's disease in Chinese population. Yang ZH; Li YS; Shi MM; Yang J; Liu YT; Mao CY; Fan Y; Hu XC; Shi CH; Xu YM J Neurol; 2019 Jul; 266(7):1796-1800. PubMed ID: 31041581 [TBL] [Abstract][Full Text] [Related]
38. Essential role of cyclin-G-associated kinase (Auxilin-2) in developing and mature mice. Lee DW; Zhao X; Yim YI; Eisenberg E; Greene LE Mol Biol Cell; 2008 Jul; 19(7):2766-76. PubMed ID: 18434600 [TBL] [Abstract][Full Text] [Related]
39. RNAi screen reveals synthetic lethality between cyclin G-associated kinase and FBXW7 by inducing aberrant mitoses. Dolly SO; Gurden MD; Drosopoulos K; Clarke P; de Bono J; Kaye S; Workman P; Linardopoulos S Br J Cancer; 2017 Sep; 117(7):954-964. PubMed ID: 28829765 [TBL] [Abstract][Full Text] [Related]
40. The clathrin-binding and J-domains of GAK support the uncoating and chaperoning of clathrin by Hsc70 in the brain. Park BC; Yim YI; Zhao X; Olszewski MB; Eisenberg E; Greene LE J Cell Sci; 2015 Oct; 128(20):3811-21. PubMed ID: 26345367 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]